Hetero is among the leading pharmaceutical companies with an established name for developing, manufacturing, and marketing affordable medicines across major therapeutic domains. Backed by strong vertical integration capabilities, Hetero is one of the leading producers of Active Pharmaceutical Ingredients (APIs) globally. The company is endowed with a huge manufacturing infrastructure spread across the world, the finest R&D team, a robust global presence, and a well-entrenched marketing network, that made it a trusted partner of choice for the leading multinational pharmaceutical companies and global procurement bodies. Today, Hetero is one of the largest producers of both Antiretroviral APIs and Finished Formulations, catering to 40% of existing HIV/AIDS treatment globally.

Hetero’s manufacturing facilities are strategically located worldwide and have been approved by stringent global regulatory authorities such as USFDA, MHRA-UK, European Medicines Agency, and few others. With an established presence in more than 145 countries, Hetero has been focusing on making affordable medicines accessible to patients worldwide. For more information on Hetero, please visit www.hetero.com